Market Overview

Stocks To Watch For January 2, 2013

Related JNJ
3 Companies Investing In Stem Cell Research
Johnson & Johnson Metal Hip Might Lead To Poisoning, Facing 6,000+ Suits
U.S., U.K. ISIS Response Differ Widely (Fox Business)
Related MIDD
EnPro Repuchases $51 Million Convertible Senior Debentures
Top 4 NASDAQ Stocks In The Diversified Machinery Industry With The Highest ROE
A 'Cheap' Stock Pick for Your 401(k) (Fox Business)

Some of the stocks that may grab investor focus today are:

The US Food and Drug Administration approved a Johnson & Johnson (NYSE: JNJ) tuberculosis drug Sirturo. Johnson & Johnson shares gained 0.07% to $70.15 in the after-hours trading session.

Middleby (NASDAQ: MIDD) bought Viking Range for $380 million in cash. Middleby shares surged 2.18% to close at $128.21 on Monday.

Wall Street expects Landec (NASDAQ: LNDC) to report its Q2 earnings at $0.16 per share on revenue of $102.69 million. Landec shares climbed 2.92% to close at $9.51 on Monday.

The US Food and Drug Administration approved Salix Pharmaceuticals Ltd's (NASDAQ: SLXP) anti-diarrheal drug for HIV/AIDS patients. Salix shares gained 1.97% to close at $40.47 on Monday.

MWI Veterinary Supply (NASDAQ: MWIV) completed the acquisition of the assets of Prescription Containers for around $17 million. MWI shares rose 0.94% to close at $110.00 on Monday.

Posted-In: Stocks To WatchEarnings News FDA M&A Pre-Market Outlook Markets Trading Ideas


Related Articles (LNDC + JNJ)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters